Letter to the Editor: HBcrAg and Prediction of Hepatocellular Carcinoma Risk.
Sign Up to like & getrecommendations! Published in 2021 at "Hepatology"
DOI: 10.1002/hep.32251
Abstract: We wish to respond to the comments received from Drs. Wu, Tseng and Kao. Our analysis was focused on comparing HBV RNA and hepatitis B core related antigen (HBcrAg) levels with existing markers of hepatitis… read more here.
Keywords: hepatocellular carcinoma; prediction hepatocellular; editor hbcrag; hbcrag ... See more keywords
Hepatitis B virus core‐related antigen (HBcrAg) as a prognostic marker for the development of hepatocellular carcinoma: A mini systematic review of the literature
Sign Up to like & getrecommendations! Published in 2022 at "Reviews in Medical Virology"
DOI: 10.1002/rmv.2353
Abstract: Chronic hepatitis B (CHB) infection is a risk factor for hepatocellular carcinoma (HCC). Previous studies showed that elevated levels of Hepatitis B Virus (HBV) DNA and HBsAg are associated with increased HCC risk in patients… read more here.
Keywords: hepatocellular carcinoma; hcc; hbcrag; hepatitis ... See more keywords
Hepatitis B core‐related antigen monitoring during peginterferon alfa treatment for HBeAg‐negative chronic hepatitis B
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Viral Hepatitis"
DOI: 10.1111/jvh.13117
Abstract: Serum Hepatitis B core‐related antigen (HBcrAg) level moderately correlates with cccDNA. We examined whether HBcrAg can add value in monitoring the effect of peginterferon (PEG‐IFN) therapy for HBeAg‐negative chronic hepatitis B (CHB) infection. Thus, serum… read more here.
Keywords: hepatitis; hbeag negative; decline; hbcrag ... See more keywords
Characteristics of HBV Novel Serum Markers across Distinct Phases in Treatment-Naïve Chronic HBV-Infected Patients
Sign Up to like & getrecommendations! Published in 2022 at "Disease Markers"
DOI: 10.1155/2022/4133283
Abstract: Methods A total of 111 patients in total from different disease phases were recruited, including 21 in immune-tolerant (IT) phase, 49 in immune-clearance (IC) phases, 29 in immune-control or low replicative (LR) phase, and 12… read more here.
Keywords: hbv rna; dna; hbv; serum ... See more keywords
HBcrAg Predicts Hepatocellular Carcinoma Development in Chronic B Hepatitis Related Liver Cirrhosis Patients Undergoing Long-Term Effective Anti-Viral
Sign Up to like & getrecommendations! Published in 2022 at "Viruses"
DOI: 10.3390/v14122671
Abstract: Hepatitis B core-related antigen (HBcrAg) is a predictor of hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients. Studies on anti-viral therapy have shown that the use of NUC therapy in HBV patients could reduce… read more here.
Keywords: long term; hcc; anti viral; therapy ... See more keywords
On-treatment monitoring of liver fibrosis with serum hepatitis B core-related antigen in chronic hepatitis B
Sign Up to like & getrecommendations! Published in 2019 at "World Journal of Gastroenterology"
DOI: 10.3748/wjg.v25.i32.4764
Abstract: BACKGROUND Non-invasive evaluation for liver fibrosis is clinically important, especially in patients with undetectable hepatitis B virus (HBV) DNA treated with nucleoside analogs. AIM To clarify the monitoring power of hepatitis B core-related antigen (HBcrAg)… read more here.
Keywords: fibrosis; regression; liver fibrosis; hepatitis ... See more keywords